$2.060
-0.049 (-2.37%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PCSA por análisis de gráficos similares
Alphio's PCSA stock price prediction model matches the current Processa Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.05 (-0.64%). The 1-week path is $2.10 (+2.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Processa Pharmaceuticals Inc?
Currently, Processa Pharmaceuticals Inc (PCSA) is not a good buy. The stock has dropped 56.19% over the past year and has a low RSI of 31.285, indicating it is oversold. Additionally, the forward P/E ratio is 0, suggesting no earnings growth is expected in the near future. The recent acquisition of Vidya, while potentially beneficial long-term, led to a sharp 38% drop in stock price, highlighting market skepticism. The main risk is the company's negative net income, which stood at -3,265,494 USD in Q2 2026, indicating ongoing financial struggles.
PCSA cerró en $2.06 el Friday, tras bajar -2.37%
Processa Pharmaceuticals Inc (PCSA) last closed at $2.06, losing -2.37%. These facts feed the 1-day and 1-week PCSA price prediction above.
Factores de la previsión
Los factores de la previsión de Processa Pharmaceuticals Inc (PCSA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PCSA, ordenadas por similitud.
Análisis de estacionalidad de PCSA
Historically the probability of a positive August return for PCSA is 0.00%. January offers the highest probability of a positive month at 37.70%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PCSA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.18 | $0.19 | $0.19 | -90.77% |
| Sep 2026 | $0.20 | $0.24 | $0.26 | -88.27% |
| Oct 2026 | $0.15 | $0.20 | $0.23 | -90.52% |
| Nov 2026 | $0.16 | $0.20 | $0.23 | -90.14% |
| Dec 2026 | $0.18 | $0.21 | $0.24 | -89.73% |
En 2026, se proyecta que Processa Pharmaceuticals Inc (PCSA) oscile entre $0.15 y $0.26.
Previsión mensual de Processa Pharmaceuticals Inc para 2026
En Aug de 2026, se proyecta que Processa Pharmaceuticals Inc promedie $0.19, con un mínimo de $0.18 y un máximo de $0.19.
En Sep de 2026, se proyecta que Processa Pharmaceuticals Inc promedie $0.24, con un mínimo de $0.20 y un máximo de $0.26.
En Oct de 2026, se proyecta que Processa Pharmaceuticals Inc promedie $0.20, con un mínimo de $0.15 y un máximo de $0.23.
En Nov de 2026, se proyecta que Processa Pharmaceuticals Inc promedie $0.20, con un mínimo de $0.16 y un máximo de $0.23.
En Dec de 2026, se proyecta que Processa Pharmaceuticals Inc promedie $0.21, con un mínimo de $0.18 y un máximo de $0.24.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.